바로가기 및 건너띄기 링크
본문 바로가기
주메뉴 바로가기

뉴스레터

home > 자료실> 뉴스레터

글자크기

SK Biopharmaceuticals to Initiate Phase 2 Trials in US - Issue 8 (Mar. 2012)

SK Biopharmaceuticals to Initiate Phase 2 Trials in US - Issue 8 (Mar. 2012) : 작성자, 작성일, 조회수, 정보 제공
작성자 관리자
작성일 2012-03-01 조회수 1,011

Issue 8 (Mar. 2012)

Views 533 Votes 0 2012.03.14 16:24:54
bg.jpg
htlogo_01.jpg
htlogo_02.jpg
Issue 8 (Mar. 2012)
htlogo_04.jpg
HT Korea News
line.jpg
?	Regulatory Harmonization Institute and Korea Health Industry Development Institute Partner to Launch 2012 Columbus Project
Regulatory Harmonization Institute and Korea Health Industry Development Institute Partner to Launch 2012 Columbus Project
ELMWOOD PARK, N.J., Feb 02, 2012 (BUSINESS WIRE) -- The Regulatory Harmonization Institute, Inc. (RHI) an international, not-for-profit association dedicated to global harmonization of drug and medical device regulatory requirements, and the Korea Health Industry Development Institute (KHIDI), the...more
SK Biopharmaceuticals to Initiate Phase 2 Trials in US
SK Biopharmaceuticals to Initiate Phase 2 Trials in US
SEOUL, South Korea, Feb 21, 2012 (BUSINESS WIRE) -- South Korean pharmaceutical company SK Biopharmaceuticals announced yesterday that they have initiated a phase 2 trial in the US for patients suffering with diabetic peripheral neuropathy using their new chemical entity SKL11197. Recently, SK Biopharmaceuticals successfully completed their phase I trials in the US...more
Sales of cosmetics grow 9.6% in 2011
Sales of cosmetics grow 9.6% in 2011
Retail sales of cosmetic products in Korea grew 9.6 percent on-year in 2011 thanks to higher demand from domestic consumers and foreign tourists, data showed Monday. Cosmetic product sales here came to 10.82 trillion won ($9.63 billion) last year, compared with 9.81 trillion won a year earlier, according to the data ...more
	Traditional tonics heat up beauty market
Traditional tonics heat up beauty market
A housewife in her early 50s, Kim Jung-won has been using Sulwhasoo's Snowise UV Protection Cream ever since she first spotted it at a local shop about 10 years ago. Though she has always been a fan of Korean cosmetics, the cosmetic brand's oriental ingredients especially attracted her. ...more
Parexel enters alliance with AMC to accelerate Korea-based drug development
Parexel enters alliance with AMC to accelerate Korea-based drug development & commercialisation programme
Parexel International Corporation, a leading global biopharmaceutical services provider, has entered into an agreement with Seoul, Korea-based ASAN Medical Center (AMC). The alliance offers clinical trial sponsors based regionally and internationally with access to high quality clinical trial services throughout...more
LG Life Science to tap generic drug market
LG Life Science to tap generic drug market
South Korea's LG Life Science said Tuesday it agreed to produce the generic version of Pfizer's anticoagulant Cilostazol and prokinetic agent Itopride, entering the local generic drug market. Pfizer will be responsible for sales. Those drugs will be the beginning of its production of various generic drugs in Korea, LG Life. ...more
	Traditional tonics heat up beauty market
To take a glance Cutting Edge medicine Equipment! 'The 28th International Medical & hospital Equipment Show'
' The 28th Korea International medical & hospital facility exhibition(KIMES 2012)', the largest health care provider festival, is held at COEX, SEOUL, from Feb.16~19. This Exhibition, for enhancing a national keep-fit, development of medical scholarship and vitalization of hospital-related industry, is hosted by Korea ...more
Columbus Pioneers News
line.jpg
SK Chemicals
line_01.jpg
First Care Serum sales break 100 billion, making a success story in the Korean Cosmetics Market
"New medication Embix S taken conveniently without water and slim enough to be carried in a wallet"
On December 8, SK Chemicals (CEO, Chang-Geun Kim) announced that it had started selling a new orally soluble film-type male impotence medication, Embix S 50mg, (Mirodenafil Oral Disintegrating Film 50mg), the first such medication in the world. The Company said that the new version of Embix is a new and... more
Hanmi Pharmaceutical
line_01.jpg
Boryung, Kanarb Breaks W10bn in 1st Year
"Phase 2 and 3 Clinical Studies Are Published in BMC, Clinical Therapeutics, and AJCD"
Hanmi pharmaceuticals announced that it has entered into a licensing agreement with AngioLab for a new anti-obesity botanical drug, ALS-L1023. ALS-L1023 is a Melissa leaf (Lemon Balm) ethyl acetate dried extract, having excellent ...more
AMOREPACIFIC
line_01.jpg
Hanmi pharmaceutical enters into agreement with Mongolian firm MEIC over supply of OTC products
"AMOREPACIFIC has published a breast health info book entitled "30 Things that Women Should Know for Breast Health."
AMOREPACIFIC (President and CEO, Kyung-Bae Suh), together with the Korean Breast Cancer Foundation (Director, Guk-Jin Choi), have released, through the publishing company Fandombooks, a book entitled "30 Things that Women Should Know for Breast Health" as part of the activities of Our Pink Ribbon Project, ...more
Hanmi pharmaceutical enters into agreement with Mongolian firm MEIC over supply of OTC products
"AMOREPACIFIC obtains Consumer Centered Management (CCM) Certificate"
AMOREPACIFIC (President and CEO, Kyung-Bae Suh) announced on January 19 the acquisition of Consumer Centered Management (CCM) Certificate from the Fair Trade Commission. CCM is an assessment and certification system which examines whether or not a company organizes all of its managerial activities ...more
Upcoming Events of KHIDI USA
line.jpg
BLSA 5th Annual Conference
 
The 3rd Oncology Clinical Trials in Emerging Regions
Korea Health Industry Development Institute USA Office,
420 Lexington Ave., Suite 2546, New York, NY 10170
T. 646.783.6090 F.646.783.6099
Email : info@khidiusa.org If you are no longer interested you can unsubscribe instantly
logo_01.jpg logo_02.jpg

댓글등록

로그인 또는 본인확인 후 작성 가능합니다.

0/250

의견입력영역